Merck KGaA (MKGAF) Stock Chart & Stock Price History $125.00 -2.15 (-1.69%) As of 08/1/2025 03:56 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock Merck KGaA Stock Price Performance The Merck KGaA (MKGAF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 28.58%, with a year-to-date return of -17.52%. In the past month, the stock has decreased 7.21%, reflecting recent market activity. As of the latest close, Merck KGaA traded at $125.00 with a market cap of $16.16 billion and volume of 272 shares. Five years ago, the stock traded at $125.75, representing a 0.60% decrease over that period. At the time, it had a market cap of $16.64 billion and a volume of 136 shares. Receive MKGAF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.02%1 Month Performance-7.21%3 Month Performance-11.03%Year-To-Date Performance-17.52%1 Year Performance-28.58%5 Year Performance-0.60% MKGAF Stock Chart for Saturday, August, 2, 2025 MKGAF Chart by TradingView Merck KGaA Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$128.83$125.00-2.98%$128.42$121.98272 shs$16.16 billion07/31/2025$131.79$128.83-2.24%$129.87$123.72446 shs$16.65 billion07/30/2025$134.45$131.79-1.98%$131.98$126.07222 shs$17.03 billion07/29/2025$133.00$134.45+1.09%$134.62$128.32679 shs$17.38 billion07/28/2025$134.65$133.00-1.23%$135.29$131.101,215 shs$17.19 billion07/25/2025$137.00$134.65-1.72%$134.65$129.66547 shs$17.40 billion07/24/2025$134.53$137.00+1.84%$137.20$130.87274 shs$17.71 billion07/23/2025$130.20$134.53+3.32%$134.53$128.7386 shs$17.39 billion07/22/2025$129.70$130.20+0.39%$130.94$124.50177 shs$16.83 billion07/21/2025$130.40$129.70-0.54%$131.32$127.842,673 shs$16.76 billion Get the Latest News and Ratings for MKGAF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$131.61$130.40-0.92%$133.97$130.40806 shs$16.85 billion07/17/2025$131.88$131.61-0.20%$131.70$126.25226 shs$17.01 billion07/16/2025$126.50$131.88+4.25%$131.88$131.8810 shs$17.04 billion07/15/2025$125.37$126.50+0.90%$132.75$126.501,343 shs$16.35 billion07/14/2025$133.45$125.37-6.05%$131.31$125.37822 shs$16.20 billion07/11/2025$134.75$133.45-0.96%$136.35$131.95803 shs$17.25 billion07/10/2025$134.09$134.75+0.49%$136.75$130.60384 shs$17.42 billion07/09/2025$131.80$134.09+1.74%$134.35$128.78529 shs$17.33 billion07/08/2025$129.30$131.80+1.93%$134.54$126.67516 shs$17.03 billion07/07/2025$134.76$129.30-4.05%$131.46$126.06765 shs$16.71 billion07/04/2025$134.76$134.76$134.99$129.47163 shs$17.42 billion07/03/2025$134.71$134.76+0.04%$134.99$129.47163 shs$17.42 billion07/02/2025$132.90$134.71+1.36%$134.71$130.3634 shs$17.41 billion07/01/2025$131.25$132.90+1.26%$134.95$129.05576 shs$17.18 billion Related Companies UCB Stock Price Chart MorphoSys Stock Price Chart Gemini Therapeutics Stock Price Chart Jyong Biotech Stock Price Chart Evotec Stock Price Chart Antibe Therapeutics Stock Price Chart Calliditas Therapeutics AB (publ) Stock Price Chart Zymeworks Stock Price Chart Silverback Therapeutics Stock Price Chart MBX Biosciences Stock Price Chart Receive MKGAF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Merck KGaA and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:MKGAF) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
